The combination of a PTP1B inhibitor, TNFR2 blocker, and PD‑1 antibody suppresses the progression of non‑small cell lung cancer tumors by enhancing immunocompetence
Article in Oncology Reports (September 2024)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Article in Oncology Reports (September 2024)
Article in Neuropharmacology (August 2024)
Article in Frontiers in Medicine (April 2024)